cp wire

CP Wire Articles

Merck [NYSE:MRK] and privately held Antelliq Group announced on 12/14/18 that the companies have signed a definitive agreement under which Merck will acquire Antelliq from funds advised by BC... read more

Fri, 12/14/18 - 10:40 am

Two programs (one in the US and one in the UK) offering life science companies lab space and access to capital and advisors made announcements about lab space for seed and early stage
... read more

Fri, 12/14/18 - 10:03 am
  • The vaccine received Breakthrough Therapy designation in September, 2018
  • It received Fast Track designation in October, 2017

Pfizer Inc. (NYSE:PFE) announced today... read more

Fri, 12/14/18 - 09:10 am

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from the ECLIPSE study demonstrating that Tremfya (guselkumab) was superior to Cosentyx (secukinumab)* in... read more

Wed, 12/12/18 - 10:46 am
  • VE800, is based on work showing in preclinical models that certain gut-dwelling bacterial strains potentiate cytotoxic CD8+ T cells and enhance infiltration into tumors
  • Bristol-Myers... read more
Mon, 12/10/18 - 10:57 pm

Biological Dynamics announced on 12/7/18 that its OmniVerita system has been selected as the winner of CONNECT’s Most Innovative New Product Award in the Life Science Products, Clinical Stage... read more

Fri, 12/7/18 - 10:36 am

Kallyope Inc., a leading biotechnology company focused on identifying therapeutic opportunities involving the gut-brain axis, today announced a $21 million expansion of its previously... read more

Wed, 12/5/18 - 02:44 pm
  • Ruling will confirm European regulatory exclusivity for Rubraca until at least 2028
  • Clovis also recently received a patent for using Rubraca in high doses to treat cancer in the US... read more
Tue, 12/4/18 - 09:13 am

Proteintech, the benchmark in antibodies since 2001, and BenchSci, a life science machine learning startup backed by Google’s AI fund, have announced a new partnership to accelerate science by... read more

Mon, 12/3/18 - 10:33 am

Aetna, a CVS Health business, and Ascension have joined the pilot project applying blockchain technology to improve data quality and reduce administrative costs associated with changes to health... read more

Mon, 12/3/18 - 10:10 am

ResMed (NYSE: RMD) (ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital software-as-a-service (SaaS) business solutions, announced on 12/3/18 that it has entered a... read more

Mon, 12/3/18 - 09:55 am

Vertex Pharmaceuticals (Europe) Limited announced on 11/29/18 that the European Commission has granted approval of the label extension for Kalydeco (ivacaftor) to include the treatment of... read more

Thu, 11/29/18 - 09:31 am
  • The program brings together many industry heavyweights including: WuXi NextCODE, ARCH Venture Partners, Polaris Partners and Sequoia Capital
  • The Ireland Strategic Investment Fund is... read more
Wed, 11/28/18 - 09:31 am

Biotech Showcase™, one of the largest biotech investor conferences in the world, announced on 11/27/18 this year’s conference agenda which highlights six therapeutic areas that are... read more

Tue, 11/27/18 - 10:37 am
  • Merck, Abbvie and Amgen VC groups participated
  • Rheostat is focused on developing novel treatments for neurodegeneration, cognition and rare diseases

Rheostat... read more

Mon, 11/26/18 - 10:02 am
  • Danon disease has an estimated prevalence of about 15,000-30,000 patients in the U.S. and E.U.
  • ... read more
Mon, 11/26/18 - 09:46 am

Cyclica announced on 11/26/18 a collaboration with Bayer to advance drug discovery programs by gaining insights into the polypharmacological profiles of small... read more

Mon, 11/26/18 - 09:34 am
  • Trial expected to start in 1H2019
  • Improved protocol may allow for additional claims

Following its meeting with the US Food and Drug Administration (FDA) in Washington DC... read more

Sat, 11/24/18 - 11:06 am


current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.